Miyajima Atsushi, Komoda Masayo, Akagi Keita, Yuzawa Kaoru, Yoshimasu Takashi, Yamamoto Yosuke, Hirota Takashi
Department of Biopharmaceutics, Faculty of Pharmaceutical Sciences, Tokyo University of Science, Noda-shi, Japan.
J Dermatol. 2015 Jan;42(1):87-9. doi: 10.1111/1346-8138.12728. Epub 2014 Dec 10.
As a novel method improving the safety of conventional oral ivermectin (IVM) for scabies treatment, we conceived an idea called the "whole-body bathing method". In this method, the patients would bathe themselves in a bathing fluid containing IVM at an effective concentration. To evaluate the feasibility of the method, we investigated the IVM concentration in the skin and plasma after bathing rats in a fluid containing 100 ng/mL of IVM. After the bathing, the concentration of IVM in the skin was more than 400 ng/g wet weight and was maintained until 8 h after the bathing. The concentration was clearly higher than that in patients taking IVM p.o. as previously reported; IVM was not detected in plasma in the present study. Thus, the method would be a preferable drug delivery system for the skin application of IVM compared with p.o. administration.
作为一种提高传统口服伊维菌素(IVM)治疗疥疮安全性的新方法,我们构思了一种名为“全身沐浴法”的方法。在这种方法中,患者将在含有有效浓度IVM的沐浴液中自行沐浴。为了评估该方法的可行性,我们在含有100 ng/mL IVM的液体中给大鼠沐浴后,研究了皮肤和血浆中的IVM浓度。沐浴后,皮肤中IVM的浓度超过400 ng/g湿重,并维持至沐浴后8小时。该浓度明显高于先前报道的口服IVM患者的浓度;在本研究中血浆中未检测到IVM。因此,与口服给药相比,该方法将是IVM皮肤应用的一种更优的给药系统。